Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb.

Thyroid cancer continues to be overdiagnosed, though the survival rate remains unchanged, according to a study published Feb. 5 in The Lancet Diabetes & Endocrinology. Here are five notes from the ...

DPP-4is were selected as the active comparator because the drugs are used at a similar stage of diabetes during ... difference in the risk for thyroid cancer was observed between the groups ...

While doctors haven’t pinpointed exact causes, certain factors significantly increase your chances of developing thyroid cancer. Women face three times higher risk than men, particularly between ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.

Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to results from a retrospective, population-based study.

the consensus has been to avoid the therapy in patients with low-risk follicular cell–derived thyroid cancer with stage I disease, involving unifocal microcarcinomas that are 10 mm in diameter ...

A woman diagnosed with cancer at the age of 20 is sharing her story to raise awareness of cancer symptoms in teenagers and young people.

However, overall, the absolute risk for thyroid cancer is low. (HealthDay News) — The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist ...